Search

everythinglearnresearchcommunity

for

Search:↓

Animals that change color with the seasons mainly do so in response to daylight changes, but climate change is causing camouflage problems that may require evolutionary changes.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Liposomes could improve how skin care products work but are costly and not very stable.

ICG-enhanced NIR laser therapy may be a promising acne treatment with improvement and no side effects.

Activating TRPV3 stops human hair growth.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Scientists turned mouse stem cells into skin cells that can grow into skin layers and structures.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Newborn mouse skin cells can grow hair and this process can be recreated in adult cells to potentially help with hair loss.

Skin fat helps with body temperature control and has other active roles in health.

Blocking β-catenin in skin cells improves hair growth during wound healing.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.